Cognios Beta Neutral Large Cap Fund’s Regeneron Pharmaceuticals REGN Stock Holding History

Cognios Beta Neutral Large Cap Fund’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$539K	Sell	560 -118	-17%	-$112K	0.7%	43
2023 Q4	$595K	Sell	678 -67	-9%	-$55.2K	0.78%	35
2023 Q3	$613K	Sell	745 -194	-21%	-$152K	0.79%	37
2023 Q2	$675K	Sell	939 -449	-32%	-$346K	0.78%	59
2023 Q1	$1.13M	Buy	1,388 +17	+1%	+$12.8K	1.07%	19
2022 Q4	$989K	Buy	+1,371	New	+$1.01M	0.95%	38

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cognios Beta Neutral Large Cap Fund's REGN Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund reduced its Regeneron Pharmaceuticals (REGN) stake by 17% in Q1 2024, selling an estimated $112K and leaving 560 shares worth $539K. The position accounts for 0.7% of the portfolio, ranked #43.

Cognios Beta Neutral Large Cap Fund first reported a position in REGN in Q4 2022 and has held it in 6 quarters since. The position peaked at $1.13M in Q1 2023. 1,310 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

Cognios Beta Neutral Large Cap Fund held 560 shares of Regeneron Pharmaceuticals worth $539K as of Q1 2024.
Cognios Beta Neutral Large Cap Fund sold 118 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $112K.
Regeneron Pharmaceuticals made up 0.7% of Cognios Beta Neutral Large Cap Fund's portfolio in Q1 2024, its #43 holding.
Cognios Beta Neutral Large Cap Fund first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 6 quarters since.
Cognios Beta Neutral Large Cap Fund's Regeneron Pharmaceuticals position peaked at $1.13M in Q1 2023.
1,310 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.